RNASE3 and Alzheimer disease: Eosinophil cationic protein (ECP) [16], released by eosinophils, exhibits antimicrobial properties and has shown to serve as a biomarker in AD, indicating eosinophil activation and contribution to the local inflammatory response in the skin, leading to the characteristic redness, swelling, and itching seen in AD.